Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Siga Technologies Inc (NQ: SIGA )

7.210 -0.010 (-0.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 417,653
Open 7.300
Bid (Size) 6.900 (3)
Ask (Size) 7.610 (1)
Prev. Close 7.220
Today's Range 7.155 - 7.510
52wk Range 4.260 - 12.83
Shares Outstanding 71,082,944
Dividend Yield 6.24%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bragar Eagel & Squire, P.C. Is Investigating CSX, Stride, and SIGA and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
SIGA ALERT: Bragar Eagel & Squire, P.C. is Investigating SIGA Technologies, Inc. on Behalf of SIGA Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
+23.88%
+23.88%
1 Month
+3.59%
+3.59%
3 Month
-12.39%
-12.39%
6 Month
-30.61%
-30.61%
1 Year
+40.82%
+40.82%

More News

Read More
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against SIGA Technologies, Inc. (SIGA)
From Kirby McInerney LLP
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
Via Benzinga
Government Contract Win May Improve Investor Sentiment For SIGA Tech After Disappointing Trial Data: Analyst
Via Benzinga
Immunome Stock Sees RS Rating Jump To 91
Via Investor's Business Daily
GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?
Via MarketBeat
Exposures COVID-19
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
Via Investor's Business Daily
3 Promising Vaccine Stocks To Watch In The Event Of A Mpox Surge
Via Talk Markets
Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening
Via Benzinga
Stock Of The Day: Bull Trap Snares SIGA Technologies On Heels Of Mpox Study
Via Benzinga
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
Via Benzinga
Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue
Via Benzinga
Exposures Fossil Fuels
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?
Via Benzinga
Russell 2000 Set For Strongest Session In A Month As US Economy Defies Recession Fears: Small Cap Movers On Thursday
Via Benzinga
Topics ETFs Economy
Exposures Economy
Nasdaq Jumps Over 2%; Walmart Earnings Top Views
Via Benzinga
Dow Surges Over 500 Points; US Retail Sales Rise In July
Via Benzinga
Topics Stocks
Exposures US Equities
In NIH-Cosponsored Monkeypox Virus Study In Congo, SIGA Technologies' Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock Tanks
Via Benzinga
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
Via Benzinga
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
Via Benzinga
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
Via FinancialNewsMedia
Exposures COVID-19
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
From FN Media Group LLC
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.